ANGIOSTOMY CANNULA MARKET ANALYSIS

Market Challenges And Opportunities

Global Angiostosmy Cannula Market: Restraint

Product Recalls

The faults in manufacturing and production of medical devices can restrain the growth of the global angiostomy cannula market. For instance, in May 2021, BD, announced a voluntary recalling of all ethylene oxide (EtO) sterilised BD Venflon Pro Safety (VPS) and Venflon Pro IV Cannulae after identifying leakages from the injection port.

This restrain can be overcome by the introduction Good Manufacturing Practices (GMP) and observing a strict compliance with regulatory protocols.

Mechanical complications during minimally invasive cardiac surgery

Arterial cannulation can be associated with bleeding, cannula malposition causing selective cerebral perfusion, plaque dislodgement, and dissection. Dissection presents as low arterial pressure, high arterial line pressure, loss of venous return, and bluish discolouration of the vessel. Venous cannulation can be associated with bleeding, cannula malposition/air lock causing an inadequate return, leading to cerebral, splanchnic congestion or massive air embolisms. This  can restrain the growth of the global angiostomy cannula market.

Cessation of the pump and commencing retrograde cerebral perfusion can be used as a treatment, acting as a counterbalance against the given restraint.